“Brenus Pharma designs a shield against resistant cancer cells”

“Bref Eco” is an economic weekly newspaper of the Auvergne Rhones-Alpes region.

To pursue R&D and finalize preclinical studies of the first candidate targeting metastatic colorectal cancer, Brenus Pharma has just completed a seed round of €4 million seed round involving: Jacques Gardette’s familly office: Biojag ; Bpifrance and Caisse d’épargne Auvergne Limousin.

May 2022